City

Boston (1)

Cincinnati (1)

Tulsa (1)

Villejuif (1)

Condition

Anxious Depression (4)

Depression (3)

Anorexia Nervosa (1)

Anxiety Disorders (1)

Anxiety and Fear (1)

Depression, Anxiety (1)

Dysbiosis (1)

Fear (1)

Major Depressive Disorder (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Recruiting (1)

Phase

phase 4 (3)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

Laureate Institute for Brain Research, Inc. (1)

Massachusetts General Hospital (1)

University of Cincinnati (1)

Collaborator

Brain & Behavior Research Foundation (1)

California Institute of Technology (1)

Fondation de France (1)

National Institute of Mental Health (NIMH) (1)

National Institutes of Health (NIH) (1)

Intervention

duloxetine (1)

escitalopram (1)

ketamine (1)

lorazepam (1)

magnetic resonance imaging (mri) (1)

placebo (1)

stool sample (1)

Study Documents

Intervention Type

drug (3)

other (2)

biological (1)

Funder Type

Other (4)

Study Type

Interventional (3)

Observational (1)

anxious depression

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Depression, Anxiety, Fear, Depression Trial in Tulsa (Lorazepam, Placebo)

Not yet recruiting

Depression, Anxiety
+5 more

Lorazepam
Placebo

Tulsa, Oklahoma

Laureate Institute for Brain Research

Aug 16, 2023

Alteration of Symbiosis Intestinal Microbiota on Anorexia

Not yet recruiting

Anorexia Nervosa
+2 more

Stool sample

Villejuif, France

Service de Nutrition Clinique, Hôpital Paul Brousse (APHP)

Nov 21, 2022

Anxious Depression, Depression Trial in Cincinnati (Escitalopram, Duloxetine)

Recruiting

Anxious Depression
Depression

Cincinnati, Ohio

University of Cincinnati, Department of Psychiatry & Behavioral

Feb 14, 2022

Depression, Anxious Depression, MDD Trial in Boston (Ketamine, Magnetic Resonance Imaging (MRI))

Completed

Has Results

Depression
+2 more

Ketamine
Magnetic Resonance Imaging (MRI)

Boston, Massachusetts

Massachusetts General Hospital

Apr 3, 2019